Relmada Therapeutics, Inc.
RLMD • NASDAQ
Relmada Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sergio Traversa, with a market cap of $674.4M.
Market Cap$674.4M
Employees20.0
CEOSergio Traversa
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Relmada Therapeutics, Inc. FAQ
Common questions about Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026.
Relmada Therapeutics, Inc. has approximately 20 employees.